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Several guidelines and studies that address the issue of ‘best 
practice’ in the primary and secondary prevention of rheumatic 
fever (RF) have been published recently.1-4 Here I present a 
summary of the latest recommendations for the prevention of 
RF that have been distilled from these sources.
Primary prevention of RF
The prevention of the first attack of RF requires antibiotic 
treatment of suspected or proven streptococcal throat infection 
or tonsillitis in children between the ages of 3 and 15 years.4 In 
communities where RF is endemic, all cases of sore throat in 
children 3 - 15 years of age should be regarded as a streptococcal 
infection and be treated as such unless any one of the following 
clinical characteristics, which indicate that the sore throat should 
not be diagnosed as a ‘strep’ throat, is present: ulceration, 
hoarseness, watery nasal secretion, and/or conjunctivitis.1 
Children not diagnosed with streptococcal pharyngitis 
should be treated symptomatically. If laboratory services are 
available, diagnosis of ‘strep’ sore throat should be confirmed 
microbiologically, but this confirmation should not delay the 
initiation of treatment. The recommended treatment of ‘strep’ 
throat is set out in Table I.
Secondary prevention of RF
Secondary prevention requires notification of the initial attack of 
RF (and the first diagnosis of rheumatic heart disease (RHD) if 
no history of RF) in some countries (e.g. South Africa), and drug 
treatment every 2 - 4 weeks (Table II). Intramuscular penicillin 
should be encouraged in all patients; it is more effective than 
oral penicillin and results in better compliance.1,3 The new World 
Health Organization recommendations for the duration of 
secondary prevention are presented in Table III.2
Conclusion
The persisting problem of RF and RHD may be due in part 
to the failure of health care professionals to adopt existing 
guidelines on the prevention of RF.5 Penicillin, which is the 
cornerstone of any RF prevention programme, is cheap and 
widely available. The challenge is to bridge the gap between 
evidence and practice in countries where RF and RHD remain a 
major public health problem.
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Table I. Treatment of ‘strep’ throat (3 -15 years) (primary 
prevention)
 Mode of 
Antibiotic administration Dose
Benzathine  Intramuscular (keep Single dose
penicillin  child under obser- > 30 kg: 1.2 MU
 vation for 30 minutes) < 30 kg: 600 000 - 
   900 000 U
OR  
Phenoxymethyl  Oral > 30 kg: 500 mg b.d.
penicillin  or 250 mg q.i.d.
  < 30 kg: 125 mg q.i.d. 
OR  
if history of  
penicillin allergy  
(rare) 
Erythromycin Oral > 30 kg: 500 mg b.d.  
  or 250 mg q.i.d.
  < 30 kg: 125 mg q.i.d.
Table II. Secondary prevention of recurrent rheumatic fever
Antibiotic Mode of administration Dose
Benzathine  Intramuscular (keep Given every 2 - 4
penicillin child under observa- weeks
 tion for 30 minutes) > 30 kg: 1.2 MU
  < 30 kg: 600 000 -
  900 000 U
OR  
Phenoxymethyl 
penicillin Oral > 30 kg: 250 mg b.d.
  < 30 kg: 125 mg b.d.
OR 
if history of 
penicillin allergy  
Erythromycin Oral > 30 kg: 250 mg b.d.
  < 30 kg: 125 mg b.d.
Table III. World Health Organization recommendations for 
duration of secondary prevention for rheumatic fever
Category of patient Duration of secondary   
 prevention
Patient without proven carditis  For 5 years after last attack, or 
until 18 years of age (whichever 
is longer)
Patient with mild carditis (mild  For 10 years after the last attack,  
mitral regurgitation or healed or at  least until 25 years of age  
carditis) (whichever is longer) 
More severe valvular disease Lifelong
After valve surgery Lifelong
pg 240.indd   240 2/23/06   10:55:02 AM
